55 parallel-programming-"Multiple"-"Humboldt-Stiftung-Foundation" PhD positions at RMIT University in Australia
Sort by
Refine Your Search
-
The CSIRO Industry PhD Program is a four-year research training program, focusing on applied research that benefits industry by solving real-world challenges. It aims to produce the next generation
-
participating university PhD admission requirements. c) Meet university English language requirements. d) Not have previously completed a PhD. e) Be able to commence the Program in the year of the offer. f) Enrol
-
$47,000+ per year for four years $47,000+ per year for four years Applications are now open. Applications are now open. 31/12/2024 31/12/2024 1 (one) 1 (one) Be an Australian or New Zealand citizen, or Australian Permanent Resident Be an Australian or New Zealand citizen, or Australian Permanent...
-
According to the BIRS-RMIT program, students will receive a generous scholarship with nominal tuition fees from BITS, plus a full RMIT tuition fee scholarship, and stipend for the duration of your
-
Services, who is the industry partner supporting this exciting R&D project. You will also enjoy a 12-week specialised training program that will enhance your industry engagement and collaboration skills
-
Safety Products, from their Australian manufacturing facilities supporting this exciting R&D project. Receive continuous mentorship from the best in academia and industry. Enjoy a 12-week training program
-
As an AUFRANDE researcher, you will: be enrolled in doctoral programs at two entities in France and Australia, with the chance to be awarded dual doctorates work on innovative projects of high
-
unique ovarian cancer animal model and blood samples from multiple human clinical trials. The PhD candidate: The preferred PhD candidate will have done an Honours or Masters in either immunology, oncology
-
are learning more and more how it relates to human health and disease. The new generation of deep metagenomic sequencing, consists in simultaneous sequencing of multiple microbial genomes at once and has
-
) the rise of healthcare consumerism and changes in human behaviours, (ii) the multiplication of digital health innovations in an exponential world and (iii) the convergence of industries (eg: big platform